Holen Sie sich die Stockscreener-App
187.04
0.65%
1.21
Handel nachbörslich:
187.04
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BDX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$185.83
Offen:
$186.01
24-Stunden-Volumen:
2.55M
Relative Volume:
1.34
Marktkapitalisierung:
$53.61B
Einnahmen:
$21.39B
Nettoeinkommen (Verlust:
$1.61B
KGV:
33.63
EPS:
5.5609
Netto-Cashflow:
$2.55B
1W Leistung:
-2.07%
1M Leistung:
+1.32%
6M Leistung:
-8.80%
1J Leistung:
-21.45%
1-Tages-Spanne:
$185.02
$187.59
1-Wochen-Bereich:
$185.02
$192.66
52-Wochen-Spanne:
$163.33
$251.99
Becton Dickinson Co Stock (BDX) Company Profile
Firmenname
Becton Dickinson Co
Sektor
Telefon
(201) 847-6800
Adresse
ONE BECTON DR, FRANKLIN LAKES
Vergleichen Sie BDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
187.04 | 53.26B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ISRG
Intuitive Surgical Inc
|
551.25 | 193.74B | 9.61B | 2.77B | 2.27B | 7.555 |
|
RMD
Resmed Inc
|
259.21 | 37.87B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
76.10 | 37.61B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
287.22 | 21.40B | 2.96B | 487.70M | 344.00M | 6.6758 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-25 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2025-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-05-02 | Herabstufung | Goldman | Buy → Neutral |
| 2025-05-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-07-24 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-05-05 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-12-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2022-07-11 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-06-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | Fortgesetzt | Raymond James | Mkt Perform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2021-12-08 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2020-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-06-01 | Fortgesetzt | Goldman | Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-07 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-02-07 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-01-08 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-05-13 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-12-07 | Eingeleitet | Deutsche Bank | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-06-21 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-04-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-01-19 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-01-05 | Hochstufung | Citigroup | Sell → Neutral |
| 2018-01-05 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | Eingeleitet | Evercore ISI | Outperform |
| 2017-12-29 | Bestätigt | Deutsche Bank | Buy |
Alle ansehen
Becton Dickinson Co Aktie (BDX) Neueste Nachrichten
Will Becton Dickinson and Company stock outperform Dow Jones2025 Sector Review & Daily Oversold Bounce Ideas - newser.com
Technical signs of recovery in Becton Dickinson and CompanyJuly 2025 Drop Watch & Free Community Supported Trade Ideas - newser.com
Is Becton Dickinson and Company (BOX) stock a buy during volatile markets2025 Growth vs Value & Smart Allocation Stock Reports - newser.com
Is Becton Dickinson and Company (BOX) stock inflation resilientMarket Performance Summary & Proven Capital Preservation Tips - newser.com
Is Becton Dickinson and Company meeting your algorithmic filter criteriaJuly 2025 Highlights & AI Forecast Swing Trade Picks - newser.com
Should you hold or exit Becton Dickinson and Company nowSwing Trade & Free Expert Verified Stock Movement Alerts - newser.com
Will Becton Dickinson and Company stock profit from fiscal stimulusWall Street Watch & Long-Term Investment Growth Plans - newser.com
Becton Dickinson Gives South West Blood Bikes a New Permanent Home in Plymouth - Plymouth Chronicle
What Makes Becton Dickinson & Co. (BDX) a Good Investment? - MSN
Becton, Dickinson & Co. Experiences Revision in Its Stock Evaluation Amid Market Challenges - Markets Mojo
Becton, Dickinson and Company Stock: Is Wall Street Bullish or Bearish? - MSN
Here's What to Expect From Becton, Dickinson & Company’s Next Earnings Report - inkl
GCC $1.25+ Bn Catheter Market Growth Trends and Forecast to 2033 Featuring Abbott, Edwards Lifesciences, BD and Co, Boston Scientific, Medtronic, Johnson & Johnson, Stryker, Teleflex - Yahoo Finance
Will Becton Dickinson and Company see short term momentumMarket Trend Review & Real-Time Volume Analysis Alerts - newser.com
BD simplifies at-home HPV testing with new self-collection solution By Investing.com - Investing.com South Africa
BD simplifies at-home HPV testing with new self-collection solution - Investing.com Australia
BD (NYSE: BDX) unveils IVDR-certified at-home HPV self-collection with 30-day stability - Stock Titan
Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors - MarketWatch
Long term hold vs stop loss in Becton Dickinson and CompanyMarket Growth Review & AI Driven Price Forecasts - newser.com
BD launches AI-powered Incada Platform for healthcare connectivity - Medical Device Network
Is Becton Dickinson and Company stock a fit for income portfoliosJuly 2025 Catalysts & Advanced Technical Signal Analysis - newser.com
Waters-Becton, Dickinson deal cleared to close in Brazil - MLex
Becton, Dickinson and Company: A Dividend Idea With Diverse Medtech Portfolio To Meet Future Demand - Seeking Alpha
BD launches AI-enabled platform to connect medical devices By Investing.com - Investing.com Australia
BD launches AI-enabled platform to connect medical devices - Investing.com
What to do if you’re stuck in Becton Dickinson and CompanyAnalyst Downgrade & Daily Price Action Insights - newser.com
BD Launches New AI-enabled Solutions to Drive Connectivity Across Healthcare Settings - MarketScreener
Nearly 3M connected BD devices — BD's Incada™ AI Platform and Pyxis™ Pro unify device data - Stock Titan
Becton, Dickinson and Company (BDX) Stock Analysis: Evaluating a 10.14% Potential Upside - DirectorsTalk Interviews
Published on: 2025-10-19 00:28:03 - nchmf.gov.vn
Becton Dickinson's CFO to depart - MSN
Sell Signal: Will Becton Dickinson and Company stock benefit from green energy trends2025 Trade Ideas & Free Safe Capital Growth Stock Tips - Trung tâm Dự báo KTTV quốc gia
Published on: 2025-10-18 04:48:02 - Trung tâm Dự báo KTTV quốc gia
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
RBC Capital reiterates Sector Perform rating on Becton Dickinson stock By Investing.com - Investing.com Canada
Evaluating Becton Dickinson and Company with trendline analysisNew Guidance & Smart Investment Allocation Insights - newser.com
Becton Dickinson stock falls on weak Q4 sales, CFO departure news - Investing.com Canada
Becton Dickinson stock falls on weak Q4 sales, CFO departure news By Investing.com - Investing.com South Africa
BD CFO Set To Exit Company This December, Stock Falls - Benzinga
Exclusive: Ulta Beauty's new CFO is a Johnson & Johnson veteran tasked to help lead the company's next chapter - Fortune
Piper Sandler Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $200 - 富途牛牛
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Announces Target Price $211 - 富途牛牛
RBC Capital reiterates Sector Perform rating on Becton Dickinson stock - Investing.com
CFO to leave Becton Dickinson after four years - medwatch.com
BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $190 - 富途牛牛
U.S. Stocks Movement | Becton Dickinson & Co Drops Over 3% Pre-Market Despite Q4 Revenue Growth; Lowers Full-Year Sales Outlook - 富途牛牛
Becton Dickinson Delivers Steady Growth But Misses Revenue Mark - Finimize
BD announces CFO transition plan, preliminary Q4 results - MassDevice
BD Announces CFO Transition Plan - citybiz
Becton Dickinson Posts Preliminary 4Q, FY Results - 富途牛牛
Becton, Dickinson (BDX) Faces Revenue Projections Below Expectat - GuruFocus
Finanzdaten der Becton Dickinson Co-Aktie (BDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.11%
0.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):